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C om m unity  O utbreak of N o rw a lk  G astro en teritis  — G eorgia
An outbreak of gastroenteritis caused by the Norwalk virus recently occurred in Tate, a rural 
community in north Georgia. An investigation implicated the community water system as the 
source of infection.
On January 2 -3 , 1982, Tate received approximately 4.5 inches of rainfall. On January 4, 
residents in homes served by the municipal water system noted their tap water appeared turbid. 
That evening, residents reported the first cases of gastrointestinal illness. A subsequent investi­
gation by the Office of Epidemiology, Georgia Department of Human Resources, and the Envi­
ronmental Protection Division, Georgia Department of Natural Resources, included interviews 
of affected persons, a community telephone survey, testing of serum and stool samples from 
patients, and evaluation of the water system. Twenty-seven typically-ill patients identified by 
local physicians were interviewed. Illness was generally mild and was characterized by abrupt 
onset of nausea, abdominal cramps, diarrhea and/or vomiting, headache, myalgias, and low- 
grade fever. Duration of illness for most persons ranged from 1 to 3 days.
Fifty-seven households, systematically selected from a local directory, were surveyed by 
telephone. An adult member of each household provided the following information: age and 
sex of each household member and the household's water source, as well as information on the 
occurrence of gastrointestinal illness. Cases of gastrointestinal illness (defined as vomiting or 
diarrhea in the period January 1-9) were reported for 5 9 /1 9 3  (30.6%) persons in the 57 
households. However, 4 8 /7 6  (63.2%) persons living in 25 households served by the municipal 
water supply were ill, as compared with 1 1 /117  (9.4%) persons living in 32 households served 
by wells and other water sources (p < 0.001) (Figure 1). Attack rates did not vary among per­
sons in different age groups. One or more cases of illness occurred in 2 0 /2 5  (80.0%) house­
holds served by the municipal water supply, as compared with 5 /3 2  (15.6%) households 
served by other sources (p < 0.001). Based on an estimated 80 0  persons served by the water 
system, approximately 500 people may have been ill during the outbreak.
Stool cultures obtained from three acutely ill patients were negative for bacterial pathogens. 
Paired serum specimens obtained from 22 patients were tested by radioimmunoassay (RIA) for 
antibody to the Norwalk virus; a ^ 4 -fo ld  rise in antibody titer was found for 20  (90.9%) 
persons. Virus particles were not detected by electron microscopic examination of the three 
stool specimens.
The municipal water system, constructed in 1920, was using water from four sources at the 
time of the outbreak—one well and three springs. The well casing was below ground level and 
had been flooded during the heavy rains. One of the springs was located inside a fenced hog lot 
behind several houses with septic tanks; moreover, the spring was unprotected. Testing of a 
water specimen collected on January 8 from this spring revealed a fecal coliform count of >  16
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Gastroenteritis — Continued
MPN/100 ml. Tap water from a church, one of five sites sampled on January 8, had an elevated 
fecal coliform count (5.1 MPN/100  ml) and undetectable residual free chlorine. However, fecal 
conforms were not detected at four sites, where residual free chlorine levels ranged from 0.3 to 
10.0 mg/L. RIA testing of serum specimens obtained from three pigs that had access to the 
contaminated spring did not detect antibody to Norwalk virus.
On January 7 ,1 982 , use of the Tate water sources was discontinued, and water entering the 
distribution system was superchlorinated. Later that day, the system was flushed with water 
from the nearby community, which has since served as Tate's water source. For a limited time, 
Tate residents were advised to boil drinking water. There are no plans to reutilize the Tate water 
sources until the observed deficiencies are corrected.
Reported by TC Boswell, MD, DT Darnell, MD, Tate, JL Ledbetter, Georgia Dept o f Natural Resources, J  
Benson, MD, 7W McKinley, MPH, JD Smith, BS, RK Sikes, DVM, MPH, State Epidemiologist, Georgia Dept 
of Human Resources; HB Greenberg, MD, NIA/D, N/H; Field Svcs Div, Epidemiology Program Office, CDC. 
Editorial Note: The findings of this investigation strongly implicated the Tate water system as 
the source for Norwalk virus infection. Fecal contamination of tap water sampled on Friday, 
January 8, was observed at one of five sites tested, a church, where weekday water use was 
infrequent. Although data concerning water consumption by residents were not obtained, 
household residents served by the Tate system probably became infected after drinking water 
contaminated with Norwalk virus. Inspection of the four water sources for the system revealed
FIGURE 1. Gastrointestinal illness associated with a municipal water supply, Tate, 
Georgia, January 1982
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Gastroenteritis — Continued 
two possible sites of contamination, including the spring in which fecal coliforms were 
detected. That spring was subject to contamination for several reasons: the cover was 
damaged, and the spring was open to ground-water runoff from nearby homes with septic 
tanks and penned animals and to the excreta of pigs that had direct access to the spring. In 
addition, the casing of the single well was recessed below ground level and had been exposed 
to flooding by surface water during the unusually heavy rainfall. The possibility cannot be dis­
missed that inadequate chlorination of the water system contributed to the outbreak.
A variety of etiologic agents have been implicated in water-related disease outbreaks, 
including bacterial, viral, and parasitic pathogens and chemical toxins ( 1 ). The clinical and epi­
demiologic features of this outbreak were characteristic of Norwalk infection and resembled 
patterns observed in previous waterborne Norwalk-associated outbreaks involving general 
population groups (2 -5 ). This episode illustrates the importance of promptly reporting and in­
vestigating community outbreaks of gastroenteritis. A prompt response to this outbreak made 
possible identification of the causative agent and implementation of measures designed to pre­
vent future outbreaks of waterborne illness in this community.
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Dengue Type 2 Virus in East A frica
In the past year, the Virus Research Centre, Nairobi, Kenya, has received convalescent-phase 
serum samples from travelers or workers who became ill with dengue-like disease while work­
ing or visiting several areas in Somalia. More recently, acute- or convalescent-phase serum 
samples have been received from patients who lived near or visited the Kenya coast. Some of 
the sera reacted against the antigen of dengue type 2 by indirect fluorescence, but because of 
the serological overlapping within the flavivirus family, diagnosis could not be certain. Since the 
end of March 1982, 15 acute-phase serum samples have been obtained from people who de­
veloped signs of illness, and both cell lines developed slight cytopathic changes; after 
samples). Serum was inoculated into 1 -day-old mice, LLC MK2, and vero cell cultures. Mice de­
veloped signs of illness, and both cell lines developed slight cyopathic changes; after 
passaging, three virus strains were recovered: one from a tourist who visited Malindi, Kenya, in 
March and became ill upon returning to Nairobi, one from a Malindi resident who was hospital­
ized in late May, and one from a European who became ill while working in Mogadisho, Somalia, 
and returned to Nairobi on May 24.
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Indirect immunofluorescence on acetone fixed infected LLC MK2 cells using NIH arbovirus 
grouping fluids were positive for NIH Group B (flaviviruses) and dengue 1 ,2 , 3, and 4  immune 
mouse ascitic fluids. Using dengue type-specific hybridoma-derived monoclonal antibodies, 
fluorescence was seen only with monoclonal antibody against dengue type 2. After the initial 
isolate was identified, subsequent isolates were made by testing with the dengue monoclonal 
antibodies directly after acetone fixation.
Outbreaks of dengue-like disease have occurred several times in East Africa, but when viral 
agents have been isolated, they have been unrelated to the four dengue serotypes. Chikungunya 
virus was implicated in an outbreak of febrile illness in Tanganyika in the 1950s, and a closely 
related alphavirus, o'nyong-nyong virus, was responsible for a large epidemic that swept 
through eastern Africa between 1959 and 1963. Dengue virus antibodies have been detected 
in human serum in East Africa, but cross-reactivity within the flaviviruses makes implicating 
specific virus serotypes difficult. The recent rate of dengue virus isolation, considering the small 
number of acute samples (three positive of 15 tested), suggests considerable virus activity in 
East Africa. No striking increase in the number of febrile cases seen at coastal hospitals has 
been noted, but the number of cases diagnosed as "clinical malaria" appears to be higher this 
year than previously, possibly due to increased mosquito populations caused by exceptionally 
heavy rainfall in 1982. A proportion of these fever cases are likely to be dengue infections.
(Continued on page 413)
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TABLE I. Summary—cases of specified notifiable diseases. United States
30th  Week Ending Cumulative, First 30  Weeks
Disease July 31, 
1982










Aseptic meningitis 244 348 190 2,976 3,201 2,246
Brucellosis 4 3 3 89 85 105
Encephalitis: Primary (arthropod-borne 
& unspec.) 29 40 28 500 542 409
Post-infectious 2 1 6 44 61 126
Gonorrhea: Civilian 19,006 21,342 2 1,342 517,751 567,051 551 ,768
Millitary 387 443 4 9 4 14.457 16,767 1 5 ,560
Hepatitis: Type A 378 483 5 52 12,459 14,666 16,384
TypeB 402 438 3 3 0 11,761 11,618 9,480
Non A, Non B 37 N N 1,218 N N
Unspecified 167 2 1 1 179 5,167 6 ,286 5 ,740
Legionellosis 5 N N 230 N N
Leprosy 4 10 3 115 155 99
Malaria 28 55 22 542 833 398
Measles (rubeola) 23 46 178 1.090 2 .445 1 2 .434
Meningococcal infections: Total 40 40 40 1,896 2 ,328 1,755
Civilian 40 40 4 0 1,884 2 ,320 1,743
Military - - - 12 8 12
Mumps 36 41 63 3 ,972 2 ,964 10,616
Pertussis 41 35 50 648 621 734
Rubella (German measles) 24 38 87 1,837 1,605 10,309
Syphilis (Primary & Secondary): Civilian 712 557 5 10 18,565 17,153 13,661
Military 18 10 9 241 227 176
Tuberculosis 492 6 54 577 14,694 15,304 15,899
Tularemia 9 7 7 125 125 101
Typhoid fever 11 6 10 218 283 260
Typhus fever, tick-borne (RMSF) 54 60 59 596 769 632
Rabies, animal 107 12 2 96 3,595 4 ,417 2 ,790




Cum. 1982  
3
Botulism (Colo. 1) 49 Paralytic 3
Cholera - Psittacosis (Tex. 1, Upst. N.Y. 2) 76
Congenital rubella syndrome 5 Rabies, human -
Diphtheria - Tetanus (Ky. 1) 42
Leptospirosis (Ark. 1, Fla. 1) 33 Trichinosis 59
Plague 5 Typhus fever, flea-borne (endemic, murine) (Tex. 1) 20
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TABLE III. Cases of specified notifiable diseases, United States, weeks ending










Hepatitis (Viral), by type
Legionel-
losis LeprosyPrimary Post-in­











1981 1982 1982 1982 1982 1982
Cum
1982
UNITED STATES 2 44 89 500 44 517,751 567,051 378 4 02 37 167 5 115
NEW ENGLAND 22 3 16 5 12,808 14,056 11 14 14 1
Maine - - - - 613 703 5 1
N.H. 7 - - - 360 502 . 1
Vt. 1 - - - 250 2 37 2 .
Mass. 7 - 6 - 5,956 5 ,818 3 8 _■ 14
R.I. 4 - - - 858 736 _
Conn. 3 3 10 5 4,771 6 ,0 6 0 1 4 - 1
MID. ATLANTIC 7 3 57 11 65,898 6 6,553 57 60 3 6 4Upstate N Y. 3 3 21 3 10,790 10,961 22 14 2 1
N Y. City - - 11 2 7,7 34 27 ,8 60 25 8 . 1
N.J. - - 12 11,841 12,572 10 38 3 4 1
Pa. 4 - 13 8 15,533 15,160 - 1
E.N. CENTRAL 26 - 1 1 1 10 70,708 8 6,2 05 43 52 11 4 3
Ohio 4 - 36 4 21,283 28,721 16 20 8
1
2
Ind. 7 - 28 3 9,135 7 ,584 4 1
III. - - 7 1 15,341 23,921 13 7 3
Mich. 12 - 37 - 18,008 18,230 8 24 . 2 1
Wis. 3 - 3 2 6,941 7,749 2 - - 1
W.N. CENTRAL 17 13 35 3 25,516 26,855 11 4 5 3Minn. 5 - 11 1 3 ,860 4 ,2 9 3 3 2 . 1
Iowa 3 3 15 1 2 ,673 2 ,969 1 .
Mo. 1 4 4 12,050 12,235 2 2 . 4 1N. Dak. 1 - - - 342 3 75
S. Dak. - 1 . 1 682 738 . 1
Nebr. - 2 2 - 1,541 2 ,062 2 . .
^Kans. 7 3 3 4 ,368 4 ,1 8 3 3 - - 1 -
fS  ATLANTIC 64 18 83 6 123 ,453 1 39 ,550 46 113 13 28
1
1 6Del. - - - - 2,185 2 ,206 1 _Md. 2 - 14 - 17,726 15,617 1 15 1 4 2D.C. - - - - 7,737 8 ,476 . 4Va. 9 7 19 1 11,427 12,802 2 16 5 2 1 1W. Va. - - 2 - 1,569 2 ,130 2N.C. 5 9 1 22,3 82 21 ,6 20 2 10 2s.c. 1 2 - - 13,678 13,417 6 18 3 9Ga. - 1 1 9,483 2 8,9 58 5 15 1Fla. 47 8 38 4 37 ,2 66 3 4 ,3 24 29 33 3 10 3
E.S. CENTRAL 17 10 28 2 46 ,0 67 4 6 ,1 6 4 17 28 2 3Ky. - - - 6 ,176 5 ,978 7 1 1 1Tenn. 1
15
6 14 - 1 7 ,909 17,682 4 9 1 2Ala. 3 11 2 13,973 13,495 3 7 1Miss. 1 1 3 * 8 ,009 9 ,009 3 1 . .
W.S. CENTRAL 
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Utah
u ■ - 4 ,8 7 0 6 ,7 4 0 U U U u 11
Nev. * 2 869 1,045 2 3 3 1
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79 3 6 5 ,0 8 2 73,441 65 53 13 26 50
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1 ■ ■ 72 U U U u ii
V l. 1 ■ 1,722 1,863 8 5 7
Pac. Trust Terr. u * • 132 109 . . .187 267 U U U U U 10
N Not notifiable U: Unavailable
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TABLE I I I .  (Cont.'d). Cases of specified notifiable diseases, United States, weeksending
July 31, 1982 and August 1,1981 (30th week)
Reporting Area


















UNITED STATES 28 542 23 1.090 2,445 4 0 1,896 36 3,972 41 24 1,837 1,605
NEW ENGLAND 1 27 . 9 75 2 103 2 160 16 1 1 1
Maine - - - - 5 - 6 1 35 _ . 33N.H. - - - 2 6 - 14 . 12 _ . 8 43Vt. - - - 2 2 . 6 1 6 _
Mass. 1 21 - 2 54 1 27 77 . _ 4 23
R.l. - 2 - - - . 1 1 . 14 _ 1
Conn. - 4 - 3 8 1 39 - 16 - - 3 12
MID. ATLANTIC 1 71 . 151 791 5 335 3 251 8 2 88 193Upstate N Y. - 16 - 105 203 4 113 1 54 2 2 43 89N Y. City - 21 - 38 68 . 58 1 42 31 48N.J. 1 22 - 4 52 . 71 . 36 1 _ 14 46
Pa. • 12 - 4 468 1 93 1 119 5 10
E.N. CENTRAL - 36 - 66 75 5 227 1 1 2,128 7 1 153 341Ohio - 9 - 1 15 3 86 5 1,552 5 . 3Ind. - 1 - 2 8 - 22 _ 36 . 26 118III. - 4 - 23 23 - 62 2 167 1 . 55 81Mich. - 20 - 40 28 2 45 3 290 1 1 46 33
■ 2 - - 1 - 12 1 83 - - 26 106
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S. Dak. . . _ . . 1
o
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Nebr. - 3 . 3 4 9 1
































































8Ga. - 10 - - 108 . 81 . 11 7 . 6 35Fla. 1 19 - 15 207 3 102 - 43 3 - 12 49
E.S. CENTRAL - 6 . 8 5 . 123 2 37 1 40 26
■ 4 - 1
6
1 - 20 2 12 - . 22 17
Ala. " * - 2 - 52 - 14 - 1 2 8
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Guam U 1 U 5 6 U 2 u 3 U u 2 1P.R.
V I. .
4 1 81 247
22
1
- 8 - 46 1 7 3
1
Pac. Trust Terr. U - U - U - u 1 U U - 1
U: Unavailable
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TABLE III .  (Cont.'d). Cases of specified notifiable diseases. United States, weeks ending
July 31,1982 and August 1, 1981 (30th week)
Reporting Area
Syphilis (Civilian) 
























UNITED STATES 18,565 17,153 4 92 14,694 125 11 2 18 54 5 96 3,595
NEW ENGLAND 314 3 54 8 393 2 . 14 6 27
Maine 1 2 1 32 . . 20
N.H. 1 12 _ 11 _ . . . 1
Vt. 1 13 . 7 _ . 2 .
Mass. 2 10 238 7 263 2 . 10 . 3 4
R.l. 17 21 . 17 _ . . 1
Conn. 84 68 - 63 - - 2 - 1 3
MID. ATLANTIC 2,554 2 ,578 71 2,459 7 1 34 5 24 106
Upstate N Y. 255 241 21 4 22 7 1 5 5 7 53N Y. City 1,534 1,545 20 895 . . 20 1
N.J. 346 3 5 0 10 4 96 . . 5 _ 1 0 6Pa. 419 4 4 2 20 646 - - 4 - 6 47
E.N. CENTRAL 962 1.160 95 2 ,262 1 16 6 6 8 4 0 8Ohio 182 149 20 3 90 . . 8 6 56 59Ind. 116 1 1 2 1 1 299 . . . 62III. 448 657 46 926 . 3 . 2 205Mich. 158 186 14 530 . 5 _ 4
Wis. 58 56 4 117 1 - - 78
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Okla. 109 98 7 2 34 20 2 4 55
Z 1 
1 o o
Tex. 3,562 3 ,0 0 0 71 1,081 1 15 2 30
1 oz
4 53
MOUNTAIN 476 4 59 10 415 15 8 1 Q




Idaho 22 15 2 19 1 .
z 54












Ariz. 106 105 U 170 . U 4 U
1 11
Utah 13 16 . 23 7 1 27
Nev. 76 76 * 40 - 1 - 2
6
3
PACIFIC 2 ,704 2,483 77 2 .605 6 4 68 3 69Wash. 83 94 7 170 1 3
Oreg. 68 54 9 108 . . 1 '
Calif. 2 ,472 2 ,282 57 2,102 4 4 61
1
"
295Alaska 8 10 . 46 1 **
Hawaii 73 43 4 179 2 . .
73









- 2 - 31
Pac. Trust Terr. - U 68 - U - u - -
U: Unavailable
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TABLE IV. Deaths in 121 U.S. cities,* •*week ending 
July 31,1982 (30th week)
All Causes, By Age (Years)
Reporting Area
All
Ages 2^65 45 -64 25 -44 1 -24 < 1
p & r
Total
NEW ENGLAND 604 415
Boston, Mass. 175 104
Bridgeport, Conn. 47 31
Cambridge, Mass. 23 18
Fall River, Mass. 23 13
Hartford, Conn. 41 31
Lowell, Mass. 25 17
Lynn, Mass. 23 19
New Bedford, Mass 31 26
New Haven, Conn. 47 35
Providence, R.l. 62 47
Somerville, Mass. 6 5
Springfield, Mass. 28 19
Waterbury, Conn. 33 19
Worcester, Mass. 40 31
120 39 15 14 36
39 19 6 7 15
12 2 -  2 2
4 1 - - 1
4 4 1
8 - 2
8 -  -  -  1
2 2 -  -  1
4 1 - - 1
7 3 1 1 -
9 3 1 2  3
1 -  -  -  1
5 1 1 2  5
10 2 2 - 4
7 1 1 - 2




75Albany, NY. 47 30 8 7
Allentown, Pa. 17 13 4
Buffalo, N.Y. 135 88 30 9
1
4 4
Camden, N.J. 42 35 3 2 y
Elizabeth, N.J. 34 23 11
Erie, Pa t 43 30 8 2 2 i
Jersey City, N.J. 40 23 12 3 i
i
i




























Reading, Pa. 33 21 10 2
Z
Rochester, N.Y. 105 77 18 c "





Scranton, Pa t 16 13 3
/ '
Syracuse, N.Y. 83 56 21 4 i ‘
Trenton, N.J. 20 14 5
l 1
Utica, N.Y. 26 20 5 '
Yonkers, N.Y. 30 23 6 1 _
1
















































Dayton, Ohio 87 50 19 4 7
o
7
Detroit. Mich. 261 154 67 23 g QEvansville, Ind. 57 38 14 2 2 1Fort Wayne, Ind. 65 42 17 2 3
Gary, Ind. 13 7 3 1 2
Grand Rapids, Mich 56 42 8 ■j 1
Indianapolis, Ind. 164 94 46 9
1
5 10Madison, Wis. 37 22 10 3
Milwaukee, Wis. 123 92 24 5 2
Peoria, III. 37 22 6 2 4 3
Rockford, III. 45 34 4 3 1 3
South Bend, Ind. 46 35 9
1
2
Toledo, Ohio § 89 84 1 1 2


































W.N. CENTRAL 705 465
Des Moines, Iowa § 53 51
Duluth, Minn. 22 14
Kansas City. Kans. 38 26
Kansas City, Mo. 127 82
Lincoln, Nebr. 33 25
Minneapolis, Minn. 83 45
Omaha, Nebr. 73 45
St. Louis, Mo. 160 96
St. Paul, Minn. 66 43
Wichita, Kans. 50 38
140 29 30 40 31
5 . 2 1 2
S 1 1 2 1
30 5 7 3 4
5 2 1 . 1
20 11 6 1 2
22 - 2 4 8
28 6 4 26 3
15 2 3 3 2
7 2 3 - 8
All Causes, By Age (Years)
Reporting Area
All
Ages =*65 4 5 -6 4 2 5 -4 4 1-24 < 1
p & r
Total
S. ATLANTIC 1,081 662 266 82 31 37 59
Atlanta. Ga. 135 80 41 12 1 1 1
Baltimore, Md. 183 115 44 17 5 2 9
Charlotte, N.C. 82 53 15 4 4 3 9
Jacksonville, Fla 96 56 24 8 5 3 2
Miami, Fla. 91 53 24 9 5 4
Norfolk, Va. 54 25 17 6 2 4 4
Richmond, Va. 76 50 17 3 2 4 5
Savannah. Ga. 38 25 9 1 3 3
St. Petersburg, Fla 83 72 9 1 1 8
Tampa, Fla. 67 38 16 4 4 5 2
Washington, D C. 127 69 40 10 6 2 6
Wilmington, Del. 49 26 10 8 1 4 6
E.S CENTRAL 668 4 04 171 45 29 19 25
Birmingham, Ala. 104 64 27 8 3 2 -
Chattanooga, Tenn. 53 37 6 5 4 1 5
Knoxville, Tenn. 52 40 9 - 3 - 1
Louisville, Ky. 87 49 33 2 3 2
Memphis, Tenn. 174 106 44 13 4 7 8
Mobile, Ala. 45 29 6 3 7 - 2
Montgomery, Ala. 49 27 13 6 3 - 1
Nashville, Tenn. 104 52 33 8 5 6 6
W.S. CENTRAL 1,354 731 345 129 81 68 37
Austin, Tex. 55 30 16 6 3 -
Baton Rouge, La. 35 19 9 7 - - 1
Corpus Christi, Tex. 47 28 10 6 2 1 *
Dallas, Tex. 194 105 57 1 1 9 12 1
El Paso, Tex. 66 30 19 7 6 4 2
Fort Worth, Tex 81 46 14 11 1 9 2
Houston, Tex. 3 66 177 103 41 30 15 11
Little Rock, Ark. 75 48 20 3 1 3 7
New Orleans, La. 126 61 33 12 6 14 •
San Antonio, Tex. 158 90 32 13 16 7 5
Shreveport, La. 60 43 10 5 2 - 2
Tulsa, Okla. 91 54 22 7 5 3 6
MOUNTAIN 6 33 358 139 51 53 32 22
Albuquerque, N.Mex. 103 37 15 24 23 4 3
Cok). Springs, Colo. 39 26 8 . 3 2 5
Denver, Colo. 113 64 30 6 6 7 2
Las Vegas, Nev. 79 38 23 7 7 4 1
Ogden, Utah 35 21 7 2 2 3 2
Phoenix, Ariz. 128 82 31 4 4 7 2
Pueblo, Colo. 23 17 3 1 2 - 2
Salt Lake City. Utah 45 26 8 4 5 2 2
Tucson. Ariz. 68 47 14 3 1 3 3
PACIFIC 1,791 1,165 370 132 63 61 89
Berkeley. Calif. 23 15 4 4 - - 1
Fresno. Calif. 83 49 21 3 3 7 6
Glendale, Calif. 38 31 5 1 1 1
Honolulu, Hawaii 62 40 15 1 5 1 8
Long Beach, Calif. 94 62 24 5 1 2 3
Los Angeles, Calif. 583 378 1 1 2 48 26 19 20
Oakland, Calif. 54 36 11 3 2 2 1
Pasadena, Calif. 36 26 5 3 1 1 5
Portland. Oreg. 119 78 27 8 3 3 5
Sacramento, Calif. 71 45 17 4 2 3 7
San Diego, Calif. 124 62 36 14 5 7 13
San Francisco, Calif. 135 93 21 16 3 2 2
San Jose, Calif. 145 91 32 9 7 6 12
Seattle, Wash. 137 96 26 8 4 3 3
Spokane, Wash. 51 37 9 2 3 2
Tacoma, Wash. 36 26 5 3 1 1 -
TOTAL 11,600+t 7,247 2.652 823 448 425 444
* Mortality data in this table are voluntarily reported from 121 cities in the United States, most of which have populations of 100 0 00  or 
more. A death is reported by the place of its occurrence and by the week that the death certificate was filed Fetal deaths are not 
included.
•* Pneumonia and influenza
t  Because of changes in reporting methods in these 4 Pennsylvania cities, these numbers are partial counts for the current week. Com­
plete counts will be available in 4 to 6 weeks, 
t t  Total includes unknown ages.
§ Data not available. Figures are estimates based on average of past 4 weeks.
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Dengue — Continued
Reported by BK Johnson, PhD, D Ocheng, A Gichogo, PM Tukei, MB, Virus Research Centre, S Musoke, MB, 
PH Rees, MRCP, The Nairobi Hospital, L Cartwright-Taylor, PhD, Medical School, University o f Nairobi, A 
Githere, MB, Malindi D istrict Hospital, Malindi, T arap Siongok, MD, Div o f Disease Control and 
Epidemiology, M inistry o f Health, Nairobi, Kenya; Vector-Borne Diseases Div, Virology Div, Center for Infec­
tious Diseases, CDC.
Editorial Note: The first published clinical account of dengue in Africa is that of Christie ( 1 ), 
who observed an outbreak in 1870 in Zanzibar. Subsequent reports of dengue-like illness in 
East Africa, without laboratory confirmation, have been reported; confusion exists because of 
the presence of chikungunya and other viruses producing similar clinical illness. In fact, Carey 
(2) suggested that the original report in 1870 more closely described chikungunya virus than 
dengue fever. Dengue virus (types 1 and 2) has been isolated only in West Africa (Nigeria, Ivory 
Coast, Upper Volta, Senegal). However, documented dengue type 2 epidemics occurred in the 
Seychelles islands in 19 76 -197 7  and 1978 -197 9  (3,4). The Seychelles outbreaks and the ap­
pearance of dengue type 2 in Somalia and Kenya in 1982 may be the result of the frequent trade 
among India (where dengue is endemic [5]), the islands of the Indian Ocean, and East Africa. 
Another possibility, however, is extension of dengue from an enzootic transmission cycle in­
volving forest Aedes and nonhuman primates; "jungle dengue" (analagous to jungle yellow 
fever) is known to occur in Malaysia and Senegal.
Aedes aegypti, including domestic and peridomestic forms which feed readily on humans in 
and around houses, is abundant in coastal Somalia and Kenya, and is the most likely vector of 
dengue in this region. Water storage is common, providing breeding sites for A  aegypti. Other 
Aedes (Stegomyia) species (such as simpsoniand metal/icus) are also prevalent and must be 
considered potential vectors. A better definition of the transmission cycle in this region is 
needed.
In addition to the cases of dengue reported above, CDC has made serologic diagnoses in 
several Americans who visited Mogadisho, Somalia, in early 1982. Travelers to Somalia and 
coastal Kenya should be aware of the possibility of acquiring dengue and should take precau­
tions to avoid mosquito bites.
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Poliom yelitis U pdate — Jam aica
Since the first suspected case of paralytic poliomyelitis was recognized in Jamaica in late 
March 1982, a total of 56 suspected cases have been reported (Figure 2). Onset of symptoms 
in the last suspected case occurred on June 2 8 ,1 9 8 2 . No additional cases have been reported 
since June 16, 1982, from St. James Parish, where the earliest and largest number of cases 
(44) occurred.
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Poliomyelitis -  Continued
The second round of oral poliovirus vaccine (OPV) immunizations for persons 6 weeks 
through 14 years of age, the group in which 88% of the disease occurred, is presently under 
way. A third immunization round in schools and clinics is scheduled for September 1982. 
Reported by Ministry of Health, Jamaica; Div o f Viral Diseases, Center for Infectious Diseases, Immuniza­
tion Div, Quarantine Div, Center for Prevention Svcs, CDC.
Editorial Note: While active surveillance of poliomyelitis continues in Jamaica, no cases have 
been reported with onset dates more than 24  days after the initiation of the vaccination cam­
paign in a given parish, and no new suspected cases of paralytic poliomyelitis have been report­
ed during the past 5 weeks. Jamaica's Ministry of Health announced on July 29 that the out­
break of poliomyelitis was over.
The first poliomyelitis vaccine campaign delivered one dose of OPV per person to more than 
80% of the population, ages 6 weeks through 14 years, between June 1 and June 2 1 ,1 9 8 2  (/). 
The high coverage reached during this brief period appears to have terminated the outbreak of 
typel poliomyelitis in Jamaica.
Travelers to any country in which vaccine-preventable diseases are or recently have been 
endemic or epidemic should be adequately protected. Recommendations for immunizations 
have been published in the Morbidity and Mortality Weekly Report (2 -5 ).
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FIGURE 2. Suspected paralytic poliomyelitis cases, by date of onset of symptoms, 
Jamaica, March 14-August 1 ,1 9 8 2
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